10/23/2026
Sermorelin vs. Tesamorelin 🤍 What’s the difference?
Both stimulate growth hormone release, but their medical uses and supporting evidence differ.
✨ Sermorelin has a history in growth hormone testing and treating certain deficiencies in children. Evidence for adult wellness benefits remains limited.
✨ Tesamorelin, as Egrifta, is FDA-approved for excess abdominal fat in adults with HIV-associated lipodystrophy, not general weight-loss management.
Compounded versions of either medication are not FDA-approved. Medical evaluation and monitoring matter.
Save this comparison for your peptide education series 🤍
Educational only • Not a treatment recommendation